Uncategorized
Cerebrolysin: Neuropeptide Mixture in Neurodegeneration Research
May
- Cerebrolysin is a standardised porcine brain-derived neuropeptide mixture containing BDNF, NGF, CNTF, and GDNF with 25% free amino acid content.
- FPE (Free Peptide Extract) fraction molecular weight is approximately 21.4 kDa — distinguishing this compound from the single-molecule peptides in the category.
- Supplied in sterile sealed glass ampules with refrigerated storage — distinct from the lyophilized powder format of most research peptides.
What is Cerebrolysin?
Cerebrolysin is unlike most compounds in the Advanced Peptide Science research catalogue — it is a standardised porcine brain-derived neuropeptide mixture rather than a single synthetic peptide. The mixture contains four major neurotrophic factors — BDNF (brain-derived neurotrophic factor), NGF (nerve growth factor), CNTF (ciliary neurotrophic factor), and GDNF (glial cell line-derived neurotrophic factor) — alongside 25% free amino acid content. The FPE (Free Peptide Extract) fraction has an approximate molecular weight of 21.4 kDa. Supplied as sterile solution in sealed glass ampules with refrigerated storage, Cerebrolysin enables multi-factor neurotrophic research not achievable with single-molecule peptide alternatives. Researchers can access Cerebrolysin research peptide at Advanced Peptide Science.
Research Background and the Multi-Factor Approach
The standard research approach in neurotrophic biology focuses on single recombinant factors — recombinant BDNF, recombinant NGF, etc. This approach provides clean dose-response control but cannot capture the multi-factor interactions present in endogenous neurotrophic signalling. Cerebrolysin represents the alternative approach: a standardised multi-factor preparation enabling research into concurrent receptor activation across multiple neurotrophic pathways. The compound is distinctive within the Cognitive & Neurological category as the only multi-factor preparation in the catalogue.
Mechanism of Action
Mechanism research investigates concurrent activation of multiple neurotrophic receptor systems: TrkB receptor (BDNF), TrkA receptor (NGF), CNTFRα/LIFR/gp130 receptor complex (CNTF), and GFRα1/RET receptor complex (GDNF). The multi-receptor activation profile is examined for synergistic versus additive versus competing effects relative to single-factor supplementation. Downstream signalling cascades activated by combined receptor engagement include PI3K/Akt, MAPK/ERK, JAK/STAT, and PLCγ pathways — providing comprehensive neurotrophic-pathway research applications.
Key Research Findings
Multi-Factor Co-Activation
Comparative research investigates whether concurrent activation of TrkB, TrkA, CNTFRα/LIFR/gp130, and GFRα1/RET produces synergistic or additive effects relative to individual factor supplementation. The combined receptor profile is a research-tool framework for investigating multi-pathway neurotrophic signalling interactions.
Free Amino Acid Component
The 25% free amino acid content provides a metabolic substrate pool alongside the peptide neurotrophic factors. Research investigates whether the amino acid component contributes independently to neuronal viability or supports the peptide-factor signalling.
Neurodegeneration Model Research
Cerebrolysin research applications include preclinical neurodegeneration models where multi-factor neurotrophic support is hypothesised to provide broader neuronal-survival benefits than single-factor approaches. Research compares Cerebrolysin against single recombinant factors at matched receptor-activation magnitudes.
Research Applications
Cerebrolysin research applications span neurodegeneration model investigation, multi-neurotrophic pathway pharmacology, synaptic plasticity research, and comparative single-factor vs multi-factor research design. The complete Cognitive & Neurological category additionally stocks single-molecule synaptogenesis research compound Dihexa (HGF/MET pathway), the Russian neuropeptide stack Semax (BDNF upregulator) + Selank (GABA-A modulator), and the TREK-1 channel blocker PE-22-28.
Research Specifications
| Composition | Standardised porcine brain-derived neuropeptide mixture |
| Major Factors | BDNF + NGF + CNTF + GDNF |
| Free Amino Acid Content | 25% |
| FPE Fraction MW | ~21.4 kDa |
| Format | Sterile solution in sealed glass ampules |
| Available Volumes | 2ml and 5ml ampules + kit configurations |
| Storage | 2-8 °C refrigerated |
Frequently Asked Questions
How does Cerebrolysin differ from single-molecule research peptides?
Cerebrolysin is a standardised mixture of multiple neurotrophic factors (BDNF, NGF, CNTF, GDNF) rather than a single peptide. The multi-factor composition enables research into concurrent multi-receptor activation not accessible with single-molecule compounds.
Why is Cerebrolysin supplied as a solution rather than lyophilized powder?
The complex multi-factor composition is supplied as a stable sterile solution in sealed glass ampules. The refrigerated solution format maintains the mixture integrity better than lyophilization-reconstitution cycles would for a complex multi-component preparation.
Where can researchers source Cerebrolysin?
Cerebrolysin research peptide is available at Advanced Peptide Science in 2ml and 5ml ampules plus kit configurations.
Is Cerebrolysin approved for human use?
Advanced Peptide Science supplies Cerebrolysin exclusively for in vitro and in vivo scientific research. Not for human consumption. Research use only.
For Research Use Only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
